Moreover, despite the potential side effects of VEGF, such as increased vascular permeability and formation of hemangioma, the data in this study illustrates that VEGF might be considered as a therapeutic target for neurodevelopmental or neurodegenerative disorders. The gene discussed is VEGFA; the disease is hemangioma.